Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Hudson › NPI 1992759419
Hospital

Hca Health Services of Florida, INC.

Hca Health Services of Florida, INC. was paid $6.47M by Medicaid between Jan 2018 and Dec 2024, across 143 billing codes. Its largest line is 99283, emergency room visit (moderate) — 26% of everything it billed.

33Billing provider infoHCA HEALTH SERVICES OF FLORIDA, INC.
HUDSON, FL 34667
33aNPI1992759419assigned 05/20/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$6.47M
24GClaims374,611
24DCodes billed143
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Florida

Rank by total paid#71 of 163
Median peer was paid$4.77M
This provider vs. median1.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201825,336$202K
201988,966$745K
202064,988$739K
202174,537$1.38M
202263,210$1.69M
202338,197$1.07M
2024incomplete19,377$642K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 26% 22,366 20,560 $1.65M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 17% 23,183 20,074 $1.10M
74177 Computed tomography, abdomen and pelvis; with contrast material 8.5% 3,420 3,083 $549K
80053 Comprehensive metabolic panel 5.9% 21,230 16,876 $379K
70450 Computed tomography, head or brain; without contrast material 5.8% 5,100 4,212 $375K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.5% 4,438 3,749 $228K
80048 Basic metabolic panel (calcium, ionized) 3.3% 7,315 5,975 $217K
74176 Computed tomography, abdomen and pelvis; without contrast material 2.8% 1,336 1,193 $180K
84484 2.1% 10,906 7,463 $139K
99281 Emergency department visit for the evaluation and management, self-limited or minor 2.0% 1,517 1,422 $130K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.9% 2,362 2,223 $126K
72125 Computed tomography, cervical spine; without contrast material 1.6% 2,112 1,691 $102K
131 more codes
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 1.5% 964 $98K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.4% 2,159 $89K
71275 Computed tomographic angiography, chest, with contrast material 1.2% 559 $81K
87070 1.2% 3,168 $76K
J7050 Infusion, normal saline solution, 250 cc <1% 1,918 $62K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 4,225 $60K
J7030 Infusion, normal saline solution , 1000 cc <1% 10,882 $59K
71045 Radiologic examination, chest; single view <1% 13,630 $42K
85027 <1% 29,207 $39K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 990 $38K
G0378 Hospital observation service, per hour <1% 4,185 $38K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,034 $31K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 657 $28K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 4,104 $27K
81001 <1% 9,602 $26K
A9270 Non-covered item or service <1% 9,196 $26K
81025 <1% 6,184 $23K
87040 <1% 3,823 $22K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 143 $21K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,128 $19K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 421 $18K
86850 <1% 1,334 $17K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 16,523 $16K
71046 Radiologic examination, chest; 2 views <1% 2,374 $16K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 15,353 $16K
87400 <1% 3,446 $14K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 530 $13K
84702 <1% 929 $13K
96361 Intravenous infusion, hydration; each additional hour <1% 69 $13K
73564 <1% 843 $12K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 3,421 $12K
70486 <1% 87 $12K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,932 $12K
73630 <1% 905 $10K
73610 <1% 702 $10K
80076 <1% 3,961 $9K
73120 <1% 709 $9K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 21 $8K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 348 $7K
87077 <1% 1,857 $7K
72131 <1% 319 $7K
81003 <1% 2,893 $7K
85610 <1% 8,974 $6K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 131 $6K
J7120 Ringers lactate infusion, up to 1000 cc <1% 172 $6K
83880 <1% 2,299 $5K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 594 $5K
84703 <1% 3,270 $5K
85730 <1% 6,834 $5K
87205 <1% 445 $5K
83735 <1% 9,889 $4K
96375 Therapeutic injection; each additional sequential IV push <1% 6,834 $4K
74018 <1% 270 $4K
87186 <1% 1,465 $4K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,468 $4K
99213 Doctor's office visit, returning patient (routine) <1% 34 $4K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 4,519 $4K
S0028 Injection, famotidine, 20 mg <1% 812 $4K
93971 <1% 226 $4K
73110 <1% 471 $4K
73080 <1% 127 $4K
70498 <1% 32 $3K
73030 <1% 434 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 2,675 $3K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 5,934 $3K
J1644 Injection, heparin sodium, per 1000 units <1% 52 $3K
80061 Lipid panel <1% 685 $3K
12001 <1% 59 $2K
72110 <1% 155 $2K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 653 $2K
87075 <1% 18 $2K
87420 <1% 477 $2K
C1769 Guide wire <1% 145 $2K
83605 <1% 2,845 $2K
97597 <1% 43 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 5,354 $1K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 287 $1K
72128 <1% 37 $1K
72170 <1% 165 $1K
83690 <1% 7,193 $1K
74019 <1% 199 $1K
84100 <1% 1,564 $1K
84443 Thyroid stimulating hormone (TSH) <1% 1,653 $1K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 818 $919.01
76830 Ultrasound, transvaginal <1% 130 $872.70
10060 <1% 14 $859.56
J2270 Injection, morphine sulfate, up to 10 mg <1% 3,002 $828.19
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,079 $807.94
82248 <1% 1,315 $773.14
86900 <1% 1,335 $678.70
87210 <1% 72 $611.81
J3490 Unclassified drugs <1% 43 $595.50
96376 <1% 1,677 $587.64
85379 <1% 1,168 $586.16
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 15 $540.07
86901 <1% 1,330 $507.42
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 20 $481.99
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 857 $442.96
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 127 $411.34
90714 <1% 484 $337.48
93970 <1% 27 $329.35
73090 <1% 35 $291.74
84145 <1% 120 $291.33
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 65 $278.14
76377 <1% 99 $258.07
82150 <1% 660 $216.54
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 814 $195.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 965 $154.83
J2060 Injection, lorazepam, 2 mg <1% 689 $81.63
J1815 Injection, insulin, per 5 units <1% 552 $78.70
83036 Hemoglobin; glycosylated (A1C) <1% 352 $63.43
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 295 $58.02
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 65 $28.08
36415 Collection of venous blood by venipuncture <1% 62 $25.82
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 38 $15.37
J2704 Injection, propofol, 10 mg <1% 22 $11.76
84439 <1% 44 $9.14
86140 <1% 190 $3.00
87147 <1% 13 $2.59
C9113 Injection, pantoprazole sodium, per vial 0% 99 $0.00
J3370 Injection, vancomycin hcl, 500 mg 0% 57 $0.00
G1003 Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program 0% 167 $0.00
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 0% 15 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 60 $0.00
J1650 Injection, enoxaparin sodium, 10 mg 0% 62 $0.00
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 0% 37 $0.00
J1170 Injection, hydromorphone, up to 4 mg 0% 797 $0.00
85652 0% 102 $0.00
J7999 Compounded drug, not otherwise classified 0% 77 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 16 $0.00
73502 0% 16 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGREGORY, SHAWN (CFO)